Bococizumab is a novel anti-PCSK9 antibody efficiently developed to treat hypercholesterolemia. Such therapeutic agent interacts with the PCSK9 protein, a essential regulator of cholesterol concentrations. By https://bookmark-dofollow.com/story27918712/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia